I agree that this is good news. They need to put all their efforts into the pharma plant and telemedcare at this stage. One those are progressing well, they can look elsewhere to build up the company. I also agree with Buckland, awaiting news on the alternative funding arrangements.
I wonder if they took on board investors concerns that the cornerstone investment etc would have been too diluting?